Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in DNA Vaccines
| Advances in DNA Vaccines |
| Autore | Isaguliants Maria |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (210 p.) |
| Soggetto topico |
Epidemiology and Medical statistics
Medicine and Nursing |
| Soggetto non controllato |
adjuvant
adjuvants AIDS alphaviruses antibodies artificial T-cell antigens BCG bicistronic circovirus clinical trial computer design cytolytic Cytolytic T Lymphocytes DNA DNA immunization DNA vaccine DNA vaccine constructs DNA vaccines EBNA1 ebola virus disease enhancer element Epstein-Barr virus flagellin formulations gene expression HCV HCV vaccine hepatitis C virus (HCV) HIV HIV-1 HTI IL-36 immune response immune responses immunization immunogenicity in vitro transcribed mRNA influenza innate immunity intranasal latent proteins layered RNA/DNA vectors lipid LMP1 LMP2 mesenchymal stem cells (MSC) modified MSC mRNA vaccine myeloid derived suppressor cells (MDSCs) n/a nonstructural HCV proteins perforin plasmid plasmid DNA protection against tumor challenges and infectious agents rBCG recombinant particles RNA replicons T-cell therapeutic vaccine tumor regression vaccine vaccine delivery Zika |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557354503321 |
Isaguliants Maria
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Tuberculosis Drug Discovery and Development 2019
| Tuberculosis Drug Discovery and Development 2019 |
| Autore | Riccardi Giovanna |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (296 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
anti-TB drug pipeline
anti-virulence compounds antibiotic antimicrobial drug resistance (AMR) antimycobacterial antituberculosis agents artificial pneumothorax BCG bedaquiline biomarkers Carlo Forlanini caseum cell envelope clinical studies clinical trial CTVD delpazolid discovery DNA gyrase dormancy DprE1 inhibitor drug combination drug development drug discovery drug resistance drug-drug interactions EDCTP electron transport chain energy metabolism genomics granulomas host-directed therapy IAVI in vitro in vivo isoniazid lead generation lipidomics macozinone mechanism of action mechanisms of resistance metabolomics MID3 mode of action multi-drug resistance mutations mycobacteria mycobacterium Mycobacterium tuberculosis n/a oxidative phosphorylation pharmacodynamics pharmacokinetics phenotypic screening PknB PknG post-treatment sequelae privileged targets promiscuous targets proteomics pulmonary rehabilitation Q203 rifampin structure-based drug design surgery target target identification target-based drug design target-based screening TB TBVI toxicity transcriptomics tuberculosis tuberculosis treatment tuberculosis vaccines |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557627203321 |
|
Riccardi Giovanna
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||